Design, synthesis and structure-activity relationships of 3,5-diaryl-1H-pyrazoles as inhibitors of arylamine N-acetyltransferase.

Design, synthesis and structure-activity relationships of 3,5-diaryl-1H-pyrazoles as inhibitors of arylamine N-acetyltransferase.

Mostra altre versioni (1)

The synthesis and inhibitory potencies of a novel series of 3,5-diaryl-1H-pyrazoles as specific inhibitors of prokaryotic arylamine N-acetyltransferase enzymes is described. The series is based on hit compound 1 3,5-diaryl-1H-pyrazole identified from a high-throughout screen that has been carried ou...

Descrizione completa

Dettagli Bibliografici
Autori principali:	Fullam, E, Talbot, J, Abuhammed, A, Westwood, I, Davies, S, Russell, A, Sim, E
Natura:	Journal article
Lingua:	English
Pubblicazione:	2013

Documenti analoghi

Design, synthesis and structure-activity relationships of 3,5-diaryl-1H-pyrazoles as inhibitors of arylamine N-acetyltransferase.
di: Fullam, E, et al.
Pubblicazione: (2013)

Structure and mechanism of arylamine N-acetyltransferases.
di: Westwood, I, et al.
Pubblicazione: (2006)

Identification of arylamine N-acetyltransferase inhibitors as an approach towards novel anti-tuberculars.
di: Westwood, I, et al.
Pubblicazione: (2010)

Arylamine N-acetyltransferases: structural and functional implications of polymorphisms.
di: Sim, E, et al.
Pubblicazione: (2008)

Comparison of the Arylamine N-acetyltransferase from Mycobacterium marinum and Mycobacterium tuberculosis.
di: Fullam, E, et al.
Pubblicazione: (2009)

Differences between murine arylamine N-acetyltransferase type 1 and human arylamine N-acetyltransferase type 2 defined by substrate specificity and inhibitor binding
di: Laurieri, N, et al.
Pubblicazione: (2014)

Novel small-molecule inhibitors of arylamine N-acetyltransferases: drug discovery by high-throughput screening.
di: Westwood, I, et al.
Pubblicazione: (2011)

Structural Studies on the Mycobacterial Arylamine N-Acetyltransferases
di: Abuhammad, A, et al.
Pubblicazione: (2010)

Selective small molecule inhibitors of the potential breast cancer marker, human arylamine N-acetyltransferase 1, and its murine homologue, mouse arylamine N-acetyltransferase 2.
di: Russell, A, et al.
Pubblicazione: (2009)

Synthesis and in vitro evaluation of novel small molecule inhibitors of bacterial arylamine N-acetyltransferases (NATs).
di: Brooke, E, et al.
Pubblicazione: (2003)

Piperidinols that show anti-tubercular activity as inhibitors of arylamine N-acetyltransferase: an essential enzyme for mycobacterial survival inside macrophages
di: Abuhammad, A, et al.
Pubblicazione: (2012)

Probing the architecture of the Mycobacterium marinum arylamine N-acetyltransferase active site.
di: Abuhammad, A, et al.
Pubblicazione: (2010)

Arylamine N-acetyltransferase in adult mouse brain
di: Mo, M, et al.
Pubblicazione: (2004)

Piperidinols that show anti-tubercular activity as inhibitors of arylamine N-acetyltransferase: an essential enzyme for mycobacterial survival inside macrophages.
di: Areej Abuhammad, et al.
Pubblicazione: (2012-01-01)

An approach to identifying novel substrates of bacterial arylamine N-acetyltransferases.
di: Brooke, E, et al.
Pubblicazione: (2003)

Neuroendocrine expression of mouse arylamine N-acetyltransferase 2
di: Wakefield, L, et al.
Pubblicazione: (2006)

Small molecule colorimetric probes for specific detection of human arylamine N-acetyltransferase 1, a potential breast cancer biomarker.
di: Laurieri, N, et al.
Pubblicazione: (2010)

Structural investigation of mutant Mycobacterium smegmatis arylamine N-acetyltransferase: a model for a naturally occurring functional polymorphism in Mycobacterium tuberculosis arylamine N-acetyltransferase.
di: Kawamura, A, et al.
Pubblicazione: (2003)

Inhibition of mycobacterial arylamine N-acetyltransferase contributes to anti-mycobacterial activity of Warburgia salutaris.
di: Madikane, V, et al.
Pubblicazione: (2007)

Inhibition of mycobacterial arylamine N-acetyltransferase contributes to anti-mycobacterial activity of Warburgia salutaris
di: Madikane, V, et al.
Pubblicazione: (2007)

Mapping the genes for arylamine N-acetyltransferases
di: Fakis, G
Pubblicazione: (2000)

Arylamine N-acetyltransferase expression during murine heart development
di: Wakefield, L, et al.
Pubblicazione: (2004)

Expression of the genes for arylamine N-acetyltransferases in mice
di: Boukouvala, S, et al.
Pubblicazione: (2002)

Over-expression, purification, and characterization of recombinant human arylamine N-acetyltransferase 1.
di: Wang, H, et al.
Pubblicazione: (2005)

Eukaryotic arylamine N-acetyltransferase. Investigation of substrate specificity by high-throughput screening.
di: Kawamura, A, et al.
Pubblicazione: (2005)

Analysis of β-amino alcohols as inhibitors of the potential anti-tubercular target N-acetyltransferase.
di: Fullam, E, et al.
Pubblicazione: (2011)

Characterization of the putative operon containing arylamine N-acetyltransferase (nat) in Mycobacterium bovis BCG.
di: Anderton, M, et al.
Pubblicazione: (2006)

Hamster arylamine N-acetyltransferase 2: Investigation of substrate specificity by high-through-put screening
di: Kawamura, A, et al.
Pubblicazione: (2004)

Protein-ligand interactions of arylamine N-acetyltransferase from Mycobacterium smegmatis
di: Brooke, E
Pubblicazione: (2003)

Arylamine N-acetyltransferase 2 gene polymorphism in an Algerian population
di: Hiba Chelouti, et al.
Pubblicazione: (2017-08-01)

Biochemical Characterization of Arylamine N-acetyltransferases From Vibrio vulnificus
di: Xinning Liu, et al.
Pubblicazione: (2021-01-01)

Arylamine N-Acetyltransferase 1 Activity is Regulated by the Protein Acetylation Status
di: Raúl A. Salazar-González, et al.
Pubblicazione: (2022-01-01)

The structure of arylamine N-acetyltransferase from Mycobacterium smegmatis--an enzyme which inactivates the anti-tubercular drug, isoniazid.
di: Sandy, J, et al.
Pubblicazione: (2002)

Polymorphisms of arylamine N-acetyltransferase2 and risk of lung and colorectal cancer
di: Amjad Mahasneh, et al.
Pubblicazione: (2012-01-01)

Characterization of the putative operon containing arylamine N−acetyltransferase (nat) in Mycobacterium bovis BCG
di: Eltis, E
Pubblicazione: (2006)

Distribution of arylamine N-acetyltransferase 2 (NAT2) genotypes among Omanis
di: Musbah O. M. Tanira, et al.
Pubblicazione: (2003-04-01)

Humans and Chimpanzees Display Opposite Patterns of Diversity in Arylamine N-Acetyltransferase Genes
di: Christelle Vangenot, et al.
Pubblicazione: (2019-07-01)

Regioselective synthesis of 3,5-diaryl-4-methylisoxazoles
di: Lokhande, P.D., et al.
Pubblicazione: (2012)

Synthesis and photophysical investigations of pyridine-pyrazolate bound boron(III) diaryl complexes
di: Rashid Javaid, et al.
Pubblicazione: (2022-10-01)

Arylamine N-acetyltransferase-1 is highly expressed in breast cancers and conveys enhanced growth and resistance to etoposide in vitro.
di: Adam, P, et al.
Pubblicazione: (2003)